The mTOR You Know
Join Lauren Richey, PGY2 Solid Organ Transplant Pharmacy Resident at UCSF, as she reviews CMV prevention strategies in high-risk liver transplant recipients. This episode highlights the CAPSAL trial comparing antiviral prophylaxis and preemptive therapy in CMV D+/R− recipients, reviews key updates from the 2025 International CMV Consensus Guidelines, and discusses practical implications for transplant pharmacy practice.
114 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The mTOR You Know!